Status:
UNKNOWN
Hydrodissection of the Hepatoduodenal Ligament
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Hepatic Lesions
Eligibility:
All Genders
18+ years
Brief Summary
Percutaneous treatment of liver lesions adjacent to the duodenum exposes the duodenum to the risk of thermal injury, limiting removal and oncologic outcome. In this study the investigators investigate...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Major subject (≥18 years of age)
- Subject who underwent percutaneous ablation of primary or secondary liver lesions at HUS that required per-procedure hepatoduodenal ligament hydrodissection in the interventional imaging department of the New Civil Hospital from January 2019 to July 2022.
- Subject who has not expressed opposition to the reuse of their data for the purpose of this research.
- Exclusion Criteria:
- \- Opposition to the reuse of his/her data for the purpose of scientific research.
Exclusion
Key Trial Info
Start Date :
July 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 20 2025
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06190821
Start Date
July 20 2022
End Date
February 20 2025
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Imagerie interventionnelle oncologique et viscérale - CHU de Strasbourg - France
Strasbourg, France, 67091